Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
April 3, 2014	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-14-129642.pdf 0001193125-14-129642.rtf 0001193125-14-129642.xls View HTML
May 22, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-178026.pdf 0001193125-17-178026.rtf 0001193125-17-178026.xls View HTML
July 14, 2017	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-17-228620.pdf 0001193125-17-228620.rtf 0001193125-17-228620.xls View HTML
September 26, 2018	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001144204-18-050920.pdf 0001144204-18-050920.rtf 0001144204-18-050920.xls View HTML
May 16, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000002.pdf 0001517022-23-000002.rtf 0001517022-23-000002.xls View HTML
May 16, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000003.pdf 0001517022-23-000003.rtf 0001517022-23-000003.xls View HTML
May 25, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000004.pdf 0001517022-23-000004.rtf 0001517022-23-000004.xls View HTML
May 25, 2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-23-000005.pdf 0001517022-23-000005.rtf 0001517022-23-000005.xls View HTML
February 1, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000015.pdf 0001517022-24-000015.rtf View HTML
February 1, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000016.pdf 0001517022-24-000016.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax